2666-0873

JACC CardioOncology

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 953 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact953 DOIs
2

Attach ORCID iDs across 534 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact534 DOIs
3

Deposit reference lists for 124 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact124 DOIs

DOIs for this ISSN

Showing the top 5 of 953 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cardiac Tumors (10.1016/j.jaccao.2020.05.009)
Abstract ORCID
134.95 499
2 Anthracycline Cardiotoxicity in Adult Cancer Patients (10.1016/j.jaccao.2024.07.016)
Abstract ORCID
113.00 181
3 Incident Cardiovascular Disease Among Adults With Cancer (10.1016/j.jaccao.2022.01.100)
Abstract ORCID
110.61 162
4 Cardiovascular Risk Factors Are Associated With Future Cance… (10.1016/j.jaccao.2020.12.003)
Abstract ORCID
109.66 155
5 Venous and Arterial Thromboembolism in Patients With Cancer (10.1016/j.jaccao.2021.03.001)
Abstract ORCID
108.95 150
6 Cardiovascular Effects of CAR T Cell Therapy (10.1016/j.jaccao.2020.04.012)
Abstract ORCID
108.66 148
7 Efficacy of Dexrazoxane in Preventing Anthracycline Cardioto… (10.1016/j.jaccao.2019.08.003)
Abstract ORCID
107.46 140
8 ATTR Amyloidosis: Current and Emerging Management Strategies (10.1016/j.jaccao.2021.06.006)
Abstract ORCID
106.84 136
9 The Role of Cardioprotection in Cancer Therapy Cardiotoxicit… (10.1016/j.jaccao.2022.01.101)
Abstract ORCID
106.68 135
10 Early Cardiac Toxicity Associated With Post-Transplant Cyclo… (10.1016/j.jaccao.2021.02.011)
Abstract ORCID
105.86 130
11 Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven… (10.1016/j.jaccao.2020.08.007)
Abstract ORCID
105.19 126
12 Risk of Atrial Fibrillation According to Cancer Type (10.1016/j.jaccao.2021.03.006)
Abstract ORCID
104.85 124
13 Diuretic Dose and NYHA Functional Class Are Independent Pred… (10.1016/j.jaccao.2020.06.007)
Abstract ORCID
104.50 122
14 CAR T Cell Therapy–Related Cardiovascular Outcomes and Manag… (10.1016/j.jaccao.2020.02.011)
Abstract ORCID
104.32 121
15 The Evolving Immunotherapy Landscape and the Epidemiology, D… (10.1016/j.jaccao.2020.11.012)
Abstract ORCID
103.22 115
16 Hypertension in Cancer Patients and Survivors (10.1016/j.jaccao.2019.11.009)
Abstract ORCID
100.64 102
17 Myocarditis Surveillance With High-Sensitivity Troponin I Du… (10.1016/j.jaccao.2021.01.004)
Abstract ORCID
98.66 93
18 Mitochondria-Rich Extracellular Vesicles Rescue Patient-Spec… (10.1016/j.jaccao.2021.05.006)
Abstract ORCID
97.71 89
19 Electrophysiological Manifestations of Cardiac Amyloidosis (10.1016/j.jaccao.2021.07.010)
Abstract ORCID
97.47 88
20 Immune Checkpoint Inhibitor-Related Adverse Cardiovascular E… (10.1016/j.jaccao.2019.11.013)
Abstract ORCID
95.42 80
21 The Association of Sodium-Glucose Cotransporter 2 Inhibitors… (10.1016/j.jaccao.2023.03.011)
Abstract ORCID
94.60 77
22 The Novel Coronavirus Disease (COVID-19) Threat for Patients… (10.1016/j.jaccao.2020.03.001)
Abstract ORCID
93.75 74
23 Cardiometabolic Comorbidities in Cancer Survivors (10.1016/j.jaccao.2022.03.005)
Abstract ORCID
93.46 73
24 Genetics of Anthracycline Cardiomyopathy in Cancer Survivors (10.1016/j.jaccao.2020.09.006)
Abstract ORCID
92.87 71
25 Screening for Coronary Artery Disease in Cancer Survivors (10.1016/j.jaccao.2022.12.007)
Abstract ORCID
90.98 65
26 Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity (10.1016/j.jaccao.2019.06.004)
Abstract ORCID
90.65 64
27 Arterial Thromboembolism in Cancer Patients (10.1016/j.jaccao.2021.02.007)
Abstract ORCID
90.65 64
28 Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunc… (10.1016/j.jaccao.2020.06.010)
Abstract ORCID
89.97 62
29 Coronary Artery Disease in Young Women After Radiation Thera… (10.1016/j.jaccao.2021.07.008)
Abstract ORCID
89.62 61
30 Mechanistic and Clinical Overview Cardiovascular Toxicity of… (10.1016/j.jaccao.2022.01.096)
Abstract ORCID
89.62 61
31 Direct Oral Anticoagulants in Patients With Active Cancer (10.1016/j.jaccao.2020.06.001)
Abstract ORCID
89.27 60
32 The Incidence, Risk Factors, and Outcomes With 5-Fluorouraci… (10.1016/j.jaccao.2020.12.005)
Abstract ORCID
88.91 59
33 Increase in Blood Pressure Associated With Tyrosine Kinase I… (10.1016/j.jaccao.2019.08.012)
Abstract ORCID
86.62 53
34 AL Amyloidosis for the Cardiologist and Oncologist (10.1016/j.jaccao.2019.08.002)
Abstract ORCID
85.80 51
35 Immune Checkpoint Inhibitor Myocarditis Treatment Strategies… (10.1016/j.jaccao.2022.11.005)
Abstract ORCID
85.80 51
36 Incremental Value of Global Longitudinal Strain for Predicti… (10.1016/j.jaccao.2020.05.012)
Abstract ORCID
85.38 50
37 Ischemia and Bleeding in Cancer Patients Undergoing Percutan… (10.1016/j.jaccao.2019.11.001)
Abstract ORCID
84.95 49
38 Early Detection and Prediction of Anthracycline-Induced Righ… (10.1016/j.jaccao.2020.01.007)
Abstract ORCID
84.95 49
39 A Proteomic Atlas of Cardiac Amyloid Plaques (10.1016/j.jaccao.2020.08.013)
Abstract ORCID
84.51 48
40 Optimal Timing of a Physical Exercise Intervention to Improv… (10.1016/j.jaccao.2022.07.006)
Abstract ORCID
84.51 48
41 Racial and Ethnic Disparities in Cardio-Oncology (10.1016/j.jaccao.2021.05.001)
Abstract ORCID
83.14 45
42 Characterization of Immune Checkpoint Inhibitor-Related Card… (10.1016/j.jaccao.2020.07.005)
Abstract ORCID
82.66 44
43 Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubit… (10.1016/j.jaccao.2020.09.007)
Abstract ORCID
81.16 41
44 Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced… (10.1016/j.jaccao.2020.09.001)
Abstract ORCID
80.64 40
45 Cardiac Computed Tomography in Cardio-Oncology (10.1016/j.jaccao.2021.09.010)
Abstract ORCID
80.64 40
46 Cardiac Troponin in Patients With Light Chain and Transthyre… (10.1016/j.jaccao.2023.12.006)
Abstract ORCID
80.64 40
47 Effectiveness and Safety of Oral Anticoagulants Among Nonval… (10.1016/j.jaccao.2021.06.004)
Abstract ORCID
80.10 39
48 Predicting Adverse Cardiac Events After Radiotherapy for Loc… (10.1016/j.jaccao.2023.08.007)
Abstract ORCID
80.10 39
49 How to Diagnose and Manage Patients With Fluoropyrimidine-In… (10.1016/j.jaccao.2020.06.012)
Abstract ORCID
78.99 37
50 Patterns of Anticoagulation Use in Patients With Cancer With… (10.1016/j.jaccao.2020.09.008)
Abstract ORCID
78.41 36